Uncategorized

International market share gains and expanding coverage in the U.S. led the CGM maker to raise its revenue forecast for 2023.

The pullback in spending will include layoffs and lower investments in some areas of the business, company executives said.

Sanford and Fairview explored all options to keep the merger viable, but ultimately were forced to end the process due to a lack of support in Minnesota, Sanford CEO Bill Gassen said.

The payer lost 262,700 Medicaid members in the second quarter, dropping its total Medicaid lives to just over 16 million.

The lawsuit alleged the health IT vendor monopolized e-prescription drug markets for routing and eligibility through exclusivity agreements, threats and other exclusionary conduct.

The FDA aims to address challenges including inaccurate self-reported drug use, missing data and the need to show the durability of the treatment.

Alzheimer’s disease (AD) is the most common neurodegenerative disorder in the world, associated with symptoms like memory loss and cognitive impairment. Brain lesions caused by the aggregation of amyloid β (Aβ) and neurofibrillary tangles are believed to be the main cause of AD.

Stevanato Group S.p.A. today announced its financial results for the second quarter of 2023.

Merck announced that the pivotal Phase 3 KEYNOTE-756 trial investigating KEYTRUDA, Merck’s anti-PD-1 therapy, in combination with chemotherapy met one of its dual primary endpoints of pathological complete response rate following the neoadjuvant part of the neoadjuvant/adjuvant study regimen in patients with high-risk, early-stage estrogen receptor-positive, human epidermal growth factor receptor 2-negative breast cancer.

En el apasionante mundo de la aviación y la exploración espacial, el entrenamiento físico y mental de pilotos y astronautas es fundamental para garantizar su seguridad y rendimiento óptimo en condiciones extremas. Entre las múltiples herramientas utilizadas en esto …